Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: Clinical Significance of Germline BRCA Mutations
This clinical trial update discusses the clinical significance of germline BRCA mutations in patients with breast cancer and ovarian cancer.…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: Anatomopathological Analysis of the Infundibulopelvic Ligament in Patients With Ovarian Cancer
This clinical trial update outlines a study evaluating anatomopathological analysis of the infundibulopelvic ligament in patients with ovari…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors
Expanded-access update for Leap Therapeutics' DKN-01 in advanced solid tumors, noting the program is no longer available and targeting multi…
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: Comparing Intrathecal Morphine and Intraoperative Lidocaine Infusion to Epidural Anesthesia With Postoperative PCA for Patients Undergoing Exploratory Laparotomy [Phase 2]
Phase 2 trial comparing intrathecal morphine with lidocaine infusion to epidural anesthesia with postoperative PCA for exploratory laparotom…
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: An Exploratory Study on NK Cell-assisted Prevention of Bone Marrow Suppression During Chemotherapy for Ovarian Cancer [Phase 1, Phase 2]
An exploratory Phase 1/2 trial evaluating whether NK cell–assisted therapy can prevent chemotherapy-induced bone marrow suppression in ovari…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
Alaunos Therapeutics reports long-term follow-up data from subjects treated with autologous T cells engineered with a Sleeping Beauty system…
-
CLINICAL_TRIALS withdrawal · 2025-07-30Clinical Trial Update: HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
Alaunos Therapeutics reports termination of a Phase I/II autologous TCR-T cell trial across several solid tumors. The study focused on HLA t…
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: Trial in Patients With Relapsed Ovarian Cancer [Phase 2]
Reports the completion of a Phase 2 trial in relapsed ovarian cancer conducted by the Nordic Society of Gynaecological Oncology - Clinical T…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer [Phase 2]
A Phase 2 clinical trial is evaluating Abemaciclib for recurrent gynecologic cancers, including endometrial, fallopian tube, ovarian, and pr…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors [Phase 1]
An early-phase (Phase 1) study of SYN608 for advanced or metastatic solid tumors is not yet recruiting. The indications include ovarian canc…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: A Study of DS-6000a in Subjects With Advanced Renal Cell Carcinoma and Ovarian Tumors [Phase 1]
Phase 1 study evaluating DS-6000a in adults with advanced renal cell carcinoma and ovarian cancer; the trial is currently active but not rec…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: ETC-159 In Combination With Pembrolizumab In Advanced MSS/pMMR Ovarian Cancers [Phase 1]
This update describes a Phase 1 trial evaluating ETC-159 in combination with pembrolizumab for advanced MSS/pMMR platinum-resistant ovarian …
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery [Phase 2]
A Phase 2 clinical trial update for SHR-2004 Injection aimed at preventing postoperative venous thromboembolism in patients undergoing ovari…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit) [NA]
A UCSF-sponsored clinical trial called 'Tools To Be Fit' aims to improve nutrition and physical activity among cancer survivors and is curre…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Clinician Nudge to Referral of Adnexal Masses to Gynecologic Oncology [NA]
This update concerns a clinical trial examining whether a clinician nudge to refer patients with adnexal masses to gynecologic oncology impr…
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: Treat Malignant Ascites Caused by Gastrointestinal or Ovarian Cancer With M701 Bispecific Antibody [Phase 2]
Phase 2 trial update of M701 bispecific antibody for malignant ascites in gastrointestinal or ovarian cancer; the study has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies [Phase 1]
This Phase 1 study of NP-G2-044, a metastasis inhibitor, in patients with advanced or metastatic treatment-refractory solid tumors has compl…
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating systemic immune checkpoint blockade with intraperitoneal chemo-immunotherapy for recurrent ovarian …
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Safety and Efficacy of RIF Combined With Anlotinib in the Treatment of Patients With Advanced Recurrent Platinum-Resistant Ovarian Cancer: A Prospective, Multicenter Clinical Study [Phase 4]
A prospective multicenter Phase 4 trial is assessing the safety and efficacy of combining RIF with Anlotinib in patients with advanced recur…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: UNTOLD Ovarian Cancer Unmet Needs Survey
A clinical trial update for UNTOLD, a survey study by the Masonic Cancer Center at the University of Minnesota to assess unmet needs in ovar…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer [Phase 2]
Phase 2 trial evaluating body surface area-based dosing versus concentration-based dosing of cisplatin for HIPEC in women with advanced ovar…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update for SYN818 in advanced or metastatic solid tumors; currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Centralization and Oncologic Outcomes in Ovarian Cancer
Clinical trial update on centralization and oncologic outcomes in ovarian cancer; the trial is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: Rapid Pancreatic and Ovarian Screening MR Imaging With Motion Corrected T1, T2, and Advanced Diffusion Weighted Imaging for Patients With BRCA Mutation Who Undergo Screening Breast MRI
Clinical trial update on rapid pancreatic and ovarian cancer screening MRI using motion-corrected T1, T2, and advanced diffusion-weighted im…
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: Study on the Dynamic Changes of Metabolic Biomarkers and Their Prognostic Relationship in Ovarian Cancer
This clinical trial investigates how metabolic biomarkers change over time in ovarian cancer and whether these changes have prognostic signi…